2. Signaling Pathways
  3. HOXA
  4. HOXA Inhibitor

HOXA Inhibitor

HOXA Inhibitors (5):

Cat. No. Product Name Effect Purity
  • HY-134259
    MEISi-2
    		Inhibitor 98.97%
    MEISi-2 is a selective inhibitor of MEIS, a key regulator of hematopoietic stem cell (HSC) self-renewal. MEISi-2 is developed for the research of cardiac injuries, hematopoiesis issues, bone marrow transplantations, and cancer.
  • HY-132870
    MEIS-IN-2
    		Inhibitor 99.33%
    MEIS-IN-2 is a myeloid ecotropic viral integration site 1 (MEIS1) inhibitor.
  • HY-134258
    MEISi-1
    		Inhibitor 98.76%
    MEISi-1 is a homeodomain inhibitor of small molecule MEIS1 protein. MEISi-1 significantly inhibited the activity of luciferase reporter genes containing MEIS binding sites (TGACAG) and induced self-renewal of mouse and human HSCS in vitro and in vivo. MEISi-1 can be used for research in blood diseases, heart regeneration and cancer.
  • HY-132869
    MEIS-IN-1
    		Inhibitor
    MEIS-IN-1 is a potent myeloid ecotropic viral integration site (MEIS) inhibitor to induce murine and human hematopoietic stem-cell expansion.
  • HY-132871
    MEIS-IN-3
    		Inhibitor
    MEIS-IN-3 is a potent myeloid ecotropic viral integration site (MEIS) inhibitor.